Lantus News
Croup can be a serious illness in babies and young children - SouthCoastToday.com
CORRECTION: Some time ago, I wrote that Lantus insulin could be mixed with other insulins. That's an error. It should not be mixed with any other insulin. ...
UPDATE: Sanofi-Aventis 4Q Profit Up 6.2%; Sees 2008 EPS Rise - CNNMoney.com
... namely blood-thinner drug Plavix, antithrombotic Lovenox, and by diabetes treatment Lantus, which posted comparable sales growth of 14%, 17% and 31%, ...
Dr. Paul Donohue - DetNews.com
He was taken off all his oral diabetes medicines and put on Lantus insulin. It was excellent for three months, but not so now.
Sanofi-Aventis woos shareholders with major leap in dividend - Pharma Times (subscription)
There was also strong showings for cancer drug Taxotere (docetaxel), sales of which were up 14.7% to 476 million euros, while the diabetes drug Lantus ...
Pharma Sector: Few Newsmakers Of The Week - Inspire Pharma, Merck ... - RTT News
Sanofi-Aventis, which has one blockbuster diabetes drug, Lantus has initiated a late stage trial of an investigational diabetes drug GLP-1 agonist ...
Sanofi-aventis' SoloSTAR Insulin Pen for Lantus and Apidra ... - Therapeutics Daily (subscription) (press release)
"LANTUS(R) SoloSTAR(R) and APIDRA(R) SoloSTAR(R), the results of over four years of intensive development, have been designed in dialogue with patients, ...
Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra ... - PR Newswire UK (press release)
A recent survey of LANTUS(R) SoloSTAR(R) use in everyday clinical practice, involving more than 2000 people with diabetes (16% with manual dexterity ...
Blood Drug Boost Sanofi-Aventis 4Q - Houston Chronicle
The group's key drugs charted strong performances, with blood-thinner drug Plavix, antithrombotic Lovenox, and diabetes treatment Lantus posting comparable ...
High Growth Forecasted for the World Diabetes Market - PR-Inside.com (Pressemitteilung)
Actos and Lantus are existing leading products for oral anti-diabetic drugs and insulin. However, are there any others which can compete with this for ...
Novo Nordisk Fourth-Quarter Earnings Fall 43 Percent (Update1) - Bloomberg
In October, Sanofi-Aventis SA said in October third-quarter revenue from its 24-hour insulin Lantus climbed 31 percent, helped by the introduction of the ...
Lantus RSS Feed